Chu X, Braun-Heimer L, Rittner C, Schneider P M
Institute for Legal Medicine, Johannes Gutenberg University, Mainz, FRG.
Exp Clin Immunogenet. 1992;9(2):80-5.
The HLA haplotype A3-Cw6-B47-C4A91-BQ0-DR7 is associated with congenital adrenal hyperplasia (CAH), since it only carries the dysfunctional steroid 21-hydroxylase A pseudogene as well as the 5' adjacent complement C4A gene. The recombination site leading to the deletion of the complement C4B and steroid 21-hydroxylase B genes in this haplotype was studied by determining the 21-hydroxylase genomic DNA sequence in comparison to the standard CYP21A- and CYP21B-specific sequences. A 200-bp region between exons 7 and 8 was identified as a possible recombination site. Thus the deleted area comprises the 3' end of the CYP21A pseudogene, the entire C4B gene and the 5' end of the CYP21B gene. The findings were confirmed by PCR amplification of a 1.8-kb fragment of the CYP21 gene. This PCR system is specific for CYP21A/B recombinant genes and may be used for screening among CAH patients carrying this type of deletion.
HLA单倍型A3-Cw6-B47-C4A91-BQ0-DR7与先天性肾上腺皮质增生症(CAH)相关,因为它仅携带功能失调的类固醇21-羟化酶A假基因以及5'相邻的补体C4A基因。通过确定21-羟化酶基因组DNA序列并与标准CYP21A和CYP21B特异性序列进行比较,研究了该单倍型中导致补体C4B和类固醇21-羟化酶B基因缺失的重组位点。外显子7和8之间的一个200bp区域被确定为可能的重组位点。因此,缺失区域包括CYP21A假基因的3'末端、整个C4B基因和CYP21B基因的5'末端。通过对CYP21基因的1.8kb片段进行PCR扩增,证实了这些发现。该PCR系统对CYP21A/B重组基因具有特异性,可用于对携带此类缺失的CAH患者进行筛查。